14. Boden WE, O Rourke RA, Teo KK, et al. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med. 2007;356:1503 16. 15. Trikalinos TA, Alsheikh-Ali AA, Tatsioni A, et al. Percutaneous coronary interventions for non-acute coronary artery disease: a quantitative 20-year synopsis and a network meta-analysis. Lancet. 2009;373:911 8. 16. Wijeysundera HC, Nallamothu BK, Krumholz HM, et al. Meta-analysis: effects of percutaneous coronary intervention versus medical therapy on angina relief. Ann Intern Med. 2010;152:370 9. 17. Ko DT, Guo H, Wijeysundera HC, et al.Assessing the association of appro- priateness of coronary revascularization and clinical outcomes for patients with stable coronary artery disease. J Am Coll Cardiol 2012;60:1876 84. 18. Patel MR, Wolk MJ, Allen JM, et al. The privilege of self-regulation: the role of appropriate use criteria. J Am Coll Cardiol 2011;57:1557 9. 19. Chan PS, Patel MR, Klein LW, et al. Appropriateness of percutaneous coronary intervention. JAMA. 2011;306:53 61. 20. Krumholz HM, Brindis RG, Brush JE, et al. Standards for statistical models used for public reporting of health outcomes: an American Heart Association scientific statement from the Quality of Care and Outcomes Research Interdisciplinary Writing Group. Circulation 2006;113:456 62. 21. Curtis JP, Schreiner G, Wang Y, et al. All-cause readmission and repeat revascularization after percutaneous coronary intervention in a cohort of Medicare patients. J Am Coll Cardiol 2009;54:903 7. 22. Hannan EL, Zhong Y, Krumholz H, et al. 30-Day readmission for patients undergoing percutaneous coronary interventions in NewYork State. JACC Cardiovasc Interv. 2011;4:1335 42. 23. Khawaja FJ, Shah ND, Lennon RJ, et al. Factors associated with 30-day readmission rates after percutaneous coronary intervention. Arch Intern Med. 2012;172:112 7. 24. Harold JG, Bass TA, Bashore TM, et al. 